Identification and Analysis of Potential Breast Anticancer Agents in Pogostemon Cablin through Network Pharmacology
DOI:
10.29303/jppipa.v10iSpecialIssue.7049Published:
2024-08-25Issue:
Vol. 10 No. SpecialIssue (2024): Science Education, Ecotourism, Health ScienceKeywords:
Breast cancer, EGFR, Network pharmacology, Pogostemon cablin benthResearch Articles
Downloads
How to Cite
Downloads
Metrics
Abstract
Breast cancer is one of the highest known causes of death in Indonesia, especially for women. Pogostemon cablin Benth is one of the Aceh's endemic herbal plants that has been studied to have potential such as anti-inflammatory, antiproliferative, antioxidant, antimicrobial, and proapoptotic. Network pharmacology approach was conducted to explore and analyze the potential of P. cablin as an anti-breast cancer. P. cablin plant compounds were obtained from GCMS and breast cancer genes data were obtained from OMIM, GeneCard, and DisGeNet databases. Target proteins and pathways involved were identified using STRING-DB and Metascape. Network analysis was performed using Cytoscape. A total of 65 plant compounds with 554 target proteins and 1854 disease genes were obtained. Based on the results of combining protein targets using Venn diagrams, 138 overlapping proteins between drug compounds and breast cancer disease targets were identified. Based on KEGG and GO analysis, P. cablin is known to have potential in breast cancer treatment/therapeutic mechanisms. Based on the "compound-protein target-pathway" multi-target mechanism, pogostol; 1H-Cycloprop[e]azulen-7-ol, decahydro-1,1,7-trimethyl-4-methylene-, [1ar-(1aα,4aα,7β,7aβ,7bα)]-; 3-Hexen-1-ol, 2,5-dimethyl-, acetate, (Z)-, 5β,7βH,10α-Eudesm-11-en-1α-ol; Acetic acid, 3-hydroxy-6-isopropenyl-4,8a-dimethyl 1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl ester; and Humulenol-II interacts with proteins that play a significant role in breast cancer, which are MAPK1, EGFR, TNF, AKT1, and JAK2. Hence, it can be concluded that P. cablin has good potential to be a source of therapeutic treatment against breast cancer. However, it needs to be tested clinically to further determine the effects of this P. cablin compound.
References
Amberger, J. S., & Hamosh, A. (2018). Knowledgebase of Human Genes and Genetic Phenotypes. Curr Protoc Bioinformatics, 58, 1–20. https://doi.org/10.1002/cpbi.27.Searching
American Cancer Society. (2020). The American Cancer Society medical and editorial content team. Retrieved from https://www.cancer.org/cancer/diagnosis-staging/signs-and-symptoms-of-cancer.html
Bauer-Mehren, A., Rautschka, M., Sanz, F., & Furlong, L. I. (2010). DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene–disease networks. Bioinformatics, 26(22), 2924–2926. https://doi.org/10.1093/bioinformatics/btq538
Breastcancerorg. (2023). Target therapy,” breastcancer.org. Retrieved from https://www.breastcancer.org/treatment/targeted-therapy
Chien, J.-H., Lee, S.-C., Chang, K.-F., Huang, X.-F., Chen, Y.-T., & Tsai, N.-M. (2020). Extract of Pogostemon cablin Possesses Potent Anticancer Activity against Colorectal Cancer Cells In Vitro and In Vivo. Evidence-Based Complementary and Alternative Medicine, 2020(1). https://doi.org/10.1155/2020/9758156
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717
Daina, A., Michielin, O., & Zoete, V. (2019). SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 47(W1), W357–W364. https://doi.org/10.1093/nar/gkz382
Daly, P. A. (1994). Drug therapy for breast cancer. Irish Medical Journal, 87(5). Retrieved from https://www.cancer.org/cancer/types/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html
Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 1–10. https://doi.org/10.3389/fphar.2013.00177
Evans, M. K., Brown, M. C., Geradts, J., Bao, X., Robinson, T. J., Jolly, M. K., Vermeulen, P. B., Palmer, G. M., Gromeier, M., Levine, H., Morse, M. A., Van Laere, S. J., & Devi, G. R. (2018). XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype. Cancer Research, 78(7), 1726–1738. https://doi.org/10.1158/0008-5472.CAN-17-1667
Fishilevich, S., Zimmerman, S., Kohn, A., Iny Stein, T., Olender, T., Kolker, E., Safran, M., & Lancet, D. (2016). Genic insights from integrated human proteomics in GeneCards. Database, 2016, baw030. https://doi.org/10.1093/database/baw030
García-Galindo, G., Castro, J., Matés, J., Bravo, M., Ribó, M., Vilanova, M., & Benito, A. (2021). The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27KIP1. Molecules, 26(5), 1319. https://doi.org/10.3390/molecules26051319
George, B., Gui, B., Raguraman, R., Paul, A. M., Nakshatri, H., Pillai, M. R., & Kumar, R. (2022). AKT1 Transcriptomic Landscape in Breast Cancer Cells. Cells, 11(15), 2290. https://doi.org/10.3390/cells11152290
Guo, Y., Pan, W., Liu, S., Shen, Z., Xu, Y., & Hu, L. (2020). ERK/MAPK signalling pathway and tumorigenesis (Review). Experimental and Therapeutic Medicine, 1997–2007,. https://doi.org/10.3892/etm.2020.8454
He, S., Wang, T., Shi, C., Wang, Z., & Fu, X. (2022). Network pharmacology-based approach to understand the effect and mechanism of Danshen against anemia. Journal of Ethnopharmacology, 282, 114615. https://doi.org/10.1016/j.jep.2021.114615
Hochberg, Y., & Benjamini, Y. (1990). More powerful procedures for multiple significance testing. Statistics in Medicine, 9(7), 811–818. https://doi.org/10.1002/sim.4780090710
Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690. https://doi.org/10.1038/nchembio.118
Ju, J., Zhu, A., & Yuan, P. (2018). Progress in targeted therapy for breast cancer. Chronic Diseases and Translational Medicine, 4(3), 164–175. https://doi.org/10.1016/j.cdtm.2018.04.002
Kelly, K., & Bell, S. (2018). Evaluation of the reproducibility and repeatability of GCMS retention indices and mass spectra of novel psychoactive substances. Forensic Chemistry, 7, 10–18. https://doi.org/10.1016/j.forc.2017.11.002
Li, C.-W., Wu, X.-L., Zhao, X.-N., Su, Z.-Q., Chen, H.-M., Wang, X.-F., Zhang, X.-J., Zeng, H.-F., Chen, J.-N., Li, Y.-C., & Su, Z.-R. (2013). Anti‐Inflammatory Property of the Ethanol Extract of the Root and Rhizome of Pogostemon cablin (Blanco) Benth. The Scientific World Journal, 2013(1). https://doi.org/10.1155/2013/434151
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014). PI3K/AKT signaling pathway and cancer: an updated review. Annals of Medicine, 46(6), 372–383. https://doi.org/10.3109/07853890.2014.912836
Mayo, B., & Staff, C. (2015). Disease and condition Vaginitis. Mayoclinic.Org., 24, 1–7. Retrieved from https://www.mayoclinic.org/diseases-conditions/cancer/symptoms-causes/syc-20370588
Metascape.org. (2023). Metascape Gene List Analysis Report. Retrieved from https://metascape.org/gp/index.html#/reportfinal/tdcg18s8s
Miricescu, D., Totan, A., Stanescu-Spinu, I.-I., Badoiu, S. C., Stefani, C., & Greabu, M. (2020). PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. International Journal of Molecular Sciences, 22(1), 173. https://doi.org/10.3390/ijms22010173
National Cancer Institute. (2023). What Is Cancer? was originally published by the National Cancer Institute. Retrieved from https://www.cancer.gov/about-cancer/understanding/what-is-cancer
Ortega, M. A., Fraile-Martínez, O., Asúnsolo, Á., Buján, J., García-Honduvilla, N., & Coca, S. (2020). Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR. Journal of Oncology, 2020, 1–11. https://doi.org/10.1155/2020/9258396
Oshi, M., Gandhi, S., Tokumaru, Y., Wu, R., Yan, L., Yamada, A., Ishikawa, T., Endo, I., & Takabe, K. (2022). Abstract P5-03-01: Conflicting roles of EGFR expression by subtypes in breast cancer. Cancer Research, 82. https://doi.org/10.1158/1538-7445.SABCS21-P5-03-01
Piñero, J., Ramírez-Anguita, J. M., Saüch-Pitarch, J., Ronzano, F., Centeno, E., Sanz, F., & Furlong, L. I. (2019). The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Research, 48(D1), 845– 855,. https://doi.org/10.1093/nar/gkz1021
Popović-Djordjević, J., Quispe, C., Giordo, R., Kostić, A., Katanić Stanković, J. S., Tsouh Fokou, P. V., Carbone, K., Martorell, M., Kumar, M., Pintus, G., Sharifi-Rad, J., Docea, A. O., & Calina, D. (2022). Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. European Journal of Medicinal Chemistry, 233(114217), 114217. https://doi.org/10.1016/j.ejmech.2022.114217
Qasim, M., Abdullah, M., Ali Ashfaq, U., Noor, F., Nahid, N., Alzamami, A., Alturki, N. A., & Khurshid, M. (2023). Molecular mechanism of Ferula asafoetida for the treatment of asthma: Network pharmacology and molecular docking approach. Saudi Journal of Biological Sciences, 30(2), 103527. https://doi.org/10.1016/j.sjbs.2022.103527
Sari, S. L., Indra, R. L., & Lestari, R. F. (2019). Korelasi Persepsi Tentang Efek Samping Kemoterapi Dengan Kualitas Hidup Pasien Kanker Payudara. Jurnal Cakrawala Promkes, 1(2), 40. https://doi.org/10.12928/promkes.v1i2.1771
Shang, L., Wang, Y., Li, J., Zhou, F., Xiao, K., Liu, Y., Zhang, M., Wang, S., & Yang, S. (2023). Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. Journal of Ethnopharmacology, 302, 115876. https://doi.org/10.1016/j.jep.2022.115876
Sharma, B., & Yadav, D. K. (2022). Metabolomics and Network Pharmacology in the Exploration of the Multi-Targeted Therapeutic Approach of Traditional Medicinal Plants. Plants, 11(23), 3243. https://doi.org/10.3390/plants11233243
Shekar, N., Mallya, P., Gowda, D. V, & Jain, V. (2020). Triple-negative breast cancer: challenges and treatment options. International Journal of Research in Pharmaceutical Sciences, 11(2), 1977–1986. https://doi.org/10.26452/ijrps.v11i2.2127
Stelzer, G., Rosen, N., Plaschkes, I., Zimmerman, S., Twik, M., Fishilevich, S., Stein, T. I., Nudel, R., Lieder, I., Mazor, Y., Kaplan, S., Dahary, D., Warshawsky, D., Guan‐Golan, Y., Kohn, A., Rappaport, N., Safran, M., & Lancet, D. (2016). The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Current Protocols in Bioinformatics, 54(1). https://doi.org/10.1002/cpbi.5
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Syahruni, R., Umar, A. H., Rahman, H. N., & Kusuma, W. A. (2023). Exploration of Annona muricata (Annonaceae) in the Treatment of Hyperlipidemia through Network Pharmacology and Molecular Docking. Sains Malaysiana, 52(3), 899–939. https://doi.org/10.17576/jsm-2023-5203-17
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & Mering, C. von. (2019). STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131
Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., Jensen, L. J., & von Mering, C. (2021). Correction to ‘The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets.’ Nucleic Acids Research, 49(18), 10800–10800. https://doi.org/10.1093/nar/gkab835
Tian, Q., Hu, P., Wang, M., Hu, Y., Xie, L., Li, Z., Xu, Z., Liu, F., & Huang, C. (2023). Study on the mechanism of Gao-Liang-Huo decoction against dextran sulfate sodium-induced ulcerative colitis based on metabolomics and network pharmacology. Pharmacological Research - Modern Chinese Medicine, 9, 100304. https://doi.org/10.1016/j.prmcm.2023.100304
Umar, A. H., Ratnadewi, D., Rafi, M., Sulistyaningsih, Y. C., Hamim, H., & Kusuma, W. A. (2023). Drug candidates and potential targets of Curculigo spp. compounds for treating diabetes mellitus based on network pharmacology, molecular docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 41(17), 8544–8560. https://doi.org/10.1080/07391102.2022.2135597
Wang, X., Wang, Z.-Y., Zheng, J.-H., & Li, S. (2021). TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches. Chinese Journal of Natural Medicines, 19(1), 1–11. https://doi.org/10.1016/S1875-5364(21)60001-8
Wicki, A., & Rochlitz, C. (2012). Targeted therapies in breast cancer. Swiss Medical Weekly, 142(APRIL). https://doi.org/10.4414/smw.2012.13550
World Health Organization. (2013). Traditional medicine. Retrieved from https://apps.who.int/gb/ebwha/pdf_files/EB134/B134_24-en.pdf
World Health Organization. (2023a). 360 indonesia fact sheet. Retrieved from https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
World Health Organization. (2023b). Breast cancer. Retrieved from https://www.who.int/news-room/fact-sheets/detail/breast-cancer
Wu, T., Zhang, L., Li, D., Wu, T., Jiang, Y., & Zhao, L. (2021). Study on the Mechanism of Ginkgo Seeds in Treating Bronchitis by Network Pharmacology. Sains Malaysiana, 50(5), 1433–1444. https://doi.org/10.17576/jsm-2021-5005-22
Yun, S. G., Jin, S., Jeong, H. Y., Yun, H. J., Do, M. young, Kim, B. W., & Kwon, H. J. (2015). Anti-oxidant, Anti-inflammatory and Anti-cancer Effect of Methanol Extract of Pogostemon cablin. Journal of Life Science, 25(1), 44–52. https://doi.org/10.5352/JLS.2015.25.1.44
Zhang, R., Zhu, X., Bai, H., & Ning, K. (2019). Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Frontiers in Pharmacology, 10(February), 1–14,. https://doi.org/10.3389/fphar.2019.00123
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nature Communications, 10(1), 1523. https://doi.org/10.1038/s41467-019-09234-6
Zuhri, U. M., Purwaningsih, E. H., Fadilah, F., & Yuliana, N. D. (2022). Network pharmacology integrated molecular dynamics reveals the bioactive compounds and potential targets of Tinospora crispa Linn. as insulin sensitizer. PLOS ONE, 17(6), e0251837. https://doi.org/10.1371/journal.pone.0251837
Author Biographies
Syarifah Fathimah Azzahra, Department of Informatics, Faculty of Mathematic and Natural Science, Universitas Syiah Kuala, Banda Aceh, Indonesia
Essy Harnelly, Universitas Syiah Kuala, Banda Aceh, Indonesia
Muhammad Subianto, Department of Informatics, Faculty of Mathematic and Natural Science, Universitas Syiah Kuala, Banda Aceh, Indonesia
Wisnu Ananta Kusuma, Department of Computer Science, IPB University, Bogor, Indonesia
Widya Sari, Department of Biology, Faculty of Mathematic and Natural Science, Universitas Syiah Kuala, Banda Aceh, Indonesia
License
Copyright (c) 2024 Syarifah Fathimah Azzahra, Essy Harnelly, Muhammad Subianto, Wisnu Ananta Kusuma, Widya Sari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).